He would use his old political contacts to shepherd legislation to extend
pharmaceutical patents, adding up to seven years of
exclusive marketing time for new drugs that had taken too long to get through the FDA approval process.
Vets First Choice, an innovative pharmacy management and
marketing services company for veterinarians, is now the
exclusive partner pharmacy channel provider of Adequan i.m. (polysulfated glycosaminoglycan) Equine manufactured by Luitpold
Pharmaceuticals, Inc., through an agreement with Luitpold Animal Health.